Delivery Order SPE2DB24D2010-SPE2DB24FZWS2

Award Date 8/5/24
Potential Completion Date 8/6/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,308.91 firm fixed-price contract is for the delivery of 4,567,644,043 units of the prescription medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of March 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,802.45, is for the delivery of 4,568,101,166 units of the prescription medication Vyvanse 40 mg capsules. The contract has a firm fixed price and an ultimate completion date of May 2, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,144.58 firm-fixed-price contract is for the supply of 4,565,933 units of the prescription medication Vyvanse (40 mg capsules) with an ultimate completion date of September 25, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded multiple federal contracts and indefinite delivery contracts (IDCs) by various defense...
This is a $1,293 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the pharmaceutical product Vyvanse 40 mg capsules in quantities of 100. This delivery order is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,293.00 firm fixed price contract is for the delivery of 4,565,295 units of the prescription medication Vyvanse 40 mg capsules. This contract has an ultimate completion date of July 30, 2024 and was awarded on July 29, 2024. The contract is not designated with any set-aside requirements, indicating open competition....
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,784.03 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,442,116 units of the prescription drug Vyvanse 30 mg capsules. The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp (AmerisourceBergen), a major pharmaceutical distributor. The $1,641.92 contract is for the supply of 4,565,712,501 units of the prescription drug Vyvanse 40 mg capsule. The order has a firm fixed price and an ultimate completion date of September 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,646.60 firm fixed-price contract is for the delivery of 4,558,621,500 units of the prescription medication Vyvanse 40 mg capsules. The contract has a completion date of September 26, 2022 and was awarded on September 23, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $1,341.31, is for the supply of 4,565,580,632 units of the pharmaceutical product Vyvanse 60 mg capsules. The contract has a performance period that extends through August 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,337.70 firm fixed-price contract is for the delivery of 100 units of the medication Vyvanse 30 mg capsules. The contract has a completion date of June 17, 2025 and is not set-aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB24FZWS2
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,620.57 firm-fixed-price contract is for the supply of 4,565,353,170 units of the prescription medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of August 6, 2024. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a diverse range of medical products and supplies to military treatment facilities, veterans' hospitals, and other government healthcare providers. This delivery order is issued against a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive suite of pharmaceutical and medical commodities. The contract does not have a set-aside designation.

Generated 11/4/24, 11:52 AM